2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Breast
1
Conditions
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Breast Neoplasms
1
Interventions
pembrolizumab
1266
Specimen Handling
927
Magnetic Resonance Spectroscopy
835
Carboplatin
825
Cyclophosphamide
804
Cisplatin
726
Nivolumab
666
Paclitaxel
630
Radiotherapy
609
Gemcitabine
571
Biopsy
561
Bevacizumab
481
Dexamethasone
439
fludarabine
409
Docetaxel
377
venetoclax
368
Oxaliplatin
364
Fluorouracil
356
Capecitabine
355
atezolizumab
351
durvalumab
334
Rituximab
332
Drug Therapy
325
Doxorubicin
317
Radiosurgery
315
Blood Specimen Collection
310
Standard of Care
310
Pemetrexed
305
Ipilimumab
297
Radiation
287
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Association
×
1 year
×
Clear all
NCT01613482
2026-03-16
TSARINE
Centre Oscar Lambret
Phase 3
Terminated
13 enrolled
NCT06022016
2025-12-08
LUCID
Institut Claudius Regaud
Phase NA
Recruiting
910 enrolled